NDC 0093-7472-19 - Rizatriptan Benzoate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0093-7472
- Requested NDC
- 0093-7472-19
- Package NDCs from labels
- 0093-7472-19, 0093-7472-43
- Manufacturer
- Teva Pharmaceuticals USA, Inc.
- Effective date
- 2019-10-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Rizatriptan Benzoate - Teva Pharmaceuticals USA, Inc. | Teva Pharmaceuticals USA, Inc. | 2019-10-01 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-03-03 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0093-7472-19 | Rizatriptan Benzoate | 1 in 1 BLISTER PACK | TABLET | 1 | 8 | |
| 0093-7472-43 | Rizatriptan Benzoate | 18 in 1 BOX | TABLET | 18 | 8 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0093-7472-19 | EA - Each | 0093-7472 | 5402122f-c96e-4e53-addf-053fd5a517c6 | 1 | 2013-03-03 |
| 0093-7472-43 | EA - Each | 0093-7472 | 20cb0d70-de40-4fea-b74c-0a16cc678578 | 1 | 2013-03-03 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| RIZATRIPTAN BENZOATE | ACTIVE INGREDIENT | WR978S7QHH | RIZATRIPTAN BENZOATE TABLET [TEVA PHARMACEUTICALS USA INC] | 2 | |
| RIZATRIPTAN | ACTIVE MOIETY | 51086HBW8G | RIZATRIPTAN BENZOATE TABLET [TEVA PHARMACEUTICALS USA INC] | 2 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | RIZATRIPTAN BENZOATE TABLET [TEVA PHARMACEUTICALS USA INC] | 2 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | RIZATRIPTAN BENZOATE TABLET [TEVA PHARMACEUTICALS USA INC] | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | RIZATRIPTAN BENZOATE TABLET [TEVA PHARMACEUTICALS USA INC] | 2 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | RIZATRIPTAN BENZOATE TABLET [TEVA PHARMACEUTICALS USA INC] | 2 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | RIZATRIPTAN BENZOATE TABLET [TEVA PHARMACEUTICALS USA INC] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | REMEDYREPACK INC. | 1e547fac-a9e5-4c7b-adba-4e6b75141183 | 2026-09-08 | Warnings, Adverse reactions | WR978S7QHH |
| RIZAFILM | RIZATRIPTAN BENZOATE | A-S Medication Solutions | 8e36b946-cf2a-44d9-9ba7-4385cfe6b360 | 2026-08-28 | Warnings, Adverse reactions | WR978S7QHH |
| Caldesene Baby | STARCH, CORN AND ZINC OXIDE | Insight Pharmaceuticals LLC | 9f12dee2-7afa-45e9-a729-0fd42bb77715 | 2026-04-22 | Warnings | O8232NY3SJ |
| Caldesene Medicated Protecting | CORNSTARCH AND ZINC OXIDE | Insight Pharmaceuticals LLC | ffc92a0f-a7cf-4a46-b2f1-089df2bbb96b | 2026-04-22 | Warnings | O8232NY3SJ |
| RIZATRIPTAN BENZOATE | RIZATRIPTAN BENZOATE | DIRECT RX | 673d584c-0691-d2fb-e053-2991aa0a7797 | 2026-03-17 | Warnings, Adverse reactions | 314209 312840 WR978S7QHH |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Direct_Rx | f754388d-77f1-0d8d-e053-6394a90a7b7e | 2026-03-17 | Warnings, Adverse reactions | 314209 WR978S7QHH |
| Rizatriptan Benzoate ODT | RIZATRIPTAN BENZOATE ODT | Direct_rx | 2c29e066-c018-22e7-e063-6294a90a035c | 2026-03-17 | Boxed warning, Warnings, Adverse reactions | WR978S7QHH |
| RIZATRIPTAN BENZOATE | RIZATRIPTAN BENZOATE | direct rx | b3d981bc-3c9e-8a9e-e053-2995a90a8f65 | 2026-03-05 | Warnings, Adverse reactions | 314209 312840 WR978S7QHH |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Bryant Ranch Prepack | 11a7f243-3a8b-41fd-a9fa-1dd2dcafab93 | 2026-02-04 | Warnings, Adverse reactions | WR978S7QHH |
| MAXALT | RIZATRIPTAN BENZOATE | Organon LLC | 007b4644-e0e7-4863-9ae3-fe09676b3f5f | 2026-01-29 | Warnings, Adverse reactions | 314209 WR978S7QHH |
| Lotrimin Daily Sweat and Odor Control | TOPICAL STARCH | Bayer HealthCare LLC. | 9ec5c80d-b550-496f-e053-2a95a90a5489 | 2026-01-16 | Warnings | O8232NY3SJ |
| Medicated Cornstarch Baby Powder | ACTIVE CORN STARCH | Davion, Inc. | e39032d1-c8cd-4a41-af10-126970b8ad38 | 2025-12-29 | Warnings | O8232NY3SJ |
| Rizatriptan | RIZATRIPTAN | Bryant Ranch Prepack | f000d96c-42a0-4aac-96ca-8cef289979ce | 2025-11-26 | Warnings, Adverse reactions | 314209 WR978S7QHH |
| SYMBRAVO | MELOXICAM, RIZATRIPTAN | Axsome Therapeutics, Inc. | dcf1ecd1-08a0-8e47-e053-2a95a90abdc7 | 2025-11-21 | Boxed warning, Warnings, Adverse reactions | WR978S7QHH |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Bryant Ranch Prepack | 6391d2a1-252e-4e50-9d80-4dce12eabc8f | 2025-11-06 | Warnings, Adverse reactions | 312840 WR978S7QHH |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | A-S Medication Solutions | 187204ef-5370-476a-84b1-e3c54b60c6c2 | 2025-11-06 | Warnings, Adverse reactions | 314209 WR978S7QHH |
| Rizatriptan | RIZATRIPTAN | A-S Medication Solutions | 34395ed2-97b7-4220-9089-0e90169d3083 | 2025-11-05 | Warnings, Adverse reactions | 314209 WR978S7QHH |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Advanced Rx of Tennessee, LLC | 4137a02e-dcec-c14c-e063-6294a90aa44f | 2025-10-21 | Warnings, Adverse reactions | WR978S7QHH |
| RIZATRIPTAN BENZOATE | RIZATRIPTAN BENZOATE | Creekwood Pharmaceuticals LLC | b517896b-167e-47d5-801d-7458f80e8ee2 | 2025-10-09 | Warnings, Adverse reactions | 314209 312840 WR978S7QHH |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Golden State Medical Supply, Inc. | 07605de4-bef2-70e8-e063-6394a90a33cc | 2025-08-20 | Warnings, Adverse reactions | WR978S7QHH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.